Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel

Tissue Engineering

Volumn 12, Issue 5, 2006, Pages 1305-1311

  Yamamoto, Masaya ^a   Takahashi, Yoshitake ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; BIODIVERSITY; BONE; GELATION; GENETIC ENGINEERING; MEDICAL APPLICATIONS; PROTEINS; X RAY ANALYSIS;

BONE MINERAL DENSITY (BMD); BONE MORPHOGENETIC PROTEIN-2(BMP-2); GELATIN HYDROGELS; SEGMENTAL CRITICAL-SIZED DEFECTS;

HYDROGELS;

BONE MORPHOGENETIC PROTEIN 2; GELATIN; GLUTARALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABLE IMPLANT; BONE DEFECT; BONE DENSITY; BONE REGENERATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; FEASIBILITY STUDY; HYDROGEL; IMPLANTATION; ISOELECTRIC POINT; MALE; NEW ZEALAND; NONHUMAN; PRIORITY JOURNAL; RABBIT; ULNA; WATER CONTENT; X RAY;

ABSORBABLE IMPLANTS; ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE SUBSTITUTES; DELAYED-ACTION PREPARATIONS; GELATIN; HYDROGELS; RABBITS; TRANSFORMING GROWTH FACTOR BETA; ULNA FRACTURES;

ORYCTOLAGUS CUNICULUS;

EID: 33745778061     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.1305     Document Type: Article

References (16)

1. Lieberman, J.R., Daluiski, A., and Einhorn, T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J. Bone Joint Surg. Am. 84A, 1032, 2002.
2. Wozney, J.M., and Rosen, V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. Relat. Res. 346, 26, 1998.
3. Mont, M.A., Ragland, P.S., Biggins, B., Friedlaender, G., Patel, T., Cook, S., Etienne, G., Shimmin, A., Kildey, R., Rueger, D.C., and Einhorn, T.A. Use of bone morphogenetic proteins for musculoskeletal applications. An overview. J. Bone Joint Surg. Am. 86A, Suppl 2, 41, 2004.
4. Gittens, S.A., and Uludag, H. Growth factor delivery for bone tissue engineering. J. Drug Target 9, 407, 2001.
5. Geiger, M., Li, R.H., and Friess, W. Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug. Deliv. Rev. 55, 1613, 2003.
6. Hollinger, J.O., Schmitt, J.M., Buck, D.C., Shannon, R., Joh, S.P., Zegzula, H.D., and Wozney, J. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J. Biomed. Mater. Res. Appl. Biomater. 43, 356, 1998.
7. Urist, M.R., Lietze, A., and Dawson, E. β-tricalcium phosphate delivery system for bone morphogenetic protein. Clin. Orthop. Rel. Res. 187, 277, 1984.
8. Zegzula, H.D., Buck, D.C., Brekke, J., Wozney, J.M., and Hollinger, J.O. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. Am. 79, 1778, 1997.
9. Wheeler, D.L., Chamberland, D.L., Schmitt, J.M., Buck, D.C., Brekke, J.H., Hollinger, J.O., Joh, S.P., and Suh, K. W. Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model. J. Biomed. Mater. Res. Appl. Biomater. 43, 365, 1998.
10. Saito, N., Okada, T., Horiuchi, H., Murakami, N., Takahashi, J., Nawata, M., Ota, H., Nozaki, K., and Takaoka, K. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat. Biotechnol. 19, 332, 2001.
11. Zekorn, D. Intravascular retention, dispersal, excretion and break-down of gelatin plasma substitutes. Bib. Haematol. 33, 131, 1969.
12. Tabata, Y., Hijikata, S., and Ikada, Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J. Control Release 31, 189, 1994.
13. Yamamoto, M., Tabata, Y., Hong, L., Miyamoto, S., Hashimoto, N., and Ikada, Y. Bone regeneration by transforming growth factor betal released from a biodegradable hydrogel. J. Control Release 64, 133, 2000.
14. Ozeki, M., Ishii, T., Hirano, Y., and Tabata, Y. Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation. J. Drug Target 9, 461, 2001.
15. Yamamoto, M., Takahashi, Y., and Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24, 4375, 2003.
16. Hollinger, J.O., Uludag, H., and Winn, S.R. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv. Drug Deliv. Rev. 31, 303, 1998.